Prolonged prodrome, systemic vasculitis, and deafness in Cogan's syndrome

Annals of the Rheumatic Diseases

Volumn 60, Issue 1, 2001, Pages 69-71

  Van Doornum, S ^a   McColl, G ^a   Walter, M ^a   Jennens, I ^a   Bhathal, P ^a   Wicks, I P ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGAN SYNDROME; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; HEARING IMPAIRMENT; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC VASCULITIS;

ADULT; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HUMANS; IRITIS; MALE; PREDNISOLONE; SYNDROME; VASCULITIS;

EID: 0035173508     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.1.69     Document Type: Article

References (13)

1. Syndrome of non-syphilitic interstitial keratitis and vestibulo-auditory symptoms
2. Cogan's syndrome
3. Cogan's syndrome: Ophthalmic, audiovestibular, and systemic manifestations and therapy
4. Cogan syndrome: Studies in thirteen patients, long-term follow-up, and a review of the literature
5. Cogan's syndrome: 18 cases and a review of the literature
6. Cogan's syndrome
7. Cogan's syndrome: Clinical significance of antibodies against the inner ear and cornea
8. Vasculitis and Cogan's syndrome
9. Cogan's syndrome: Clinical features and outcomes
10. Weekly clinicopathological exercises
11. Progressive sensorineural hearing impairment in systemic vasculitides
12. Methotrexate therapy for hearing loss in Cogan's syndrome
13. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome